Greenwood Capital Associates LLC Pacira Bio Sciences, Inc. Transaction History
Greenwood Capital Associates LLC
- $786 Million
- Q2 2025
A detailed history of Greenwood Capital Associates LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 13,156 shares of PCRX stock, worth $326,400. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,156Holding current value
$326,400% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding PCRX
# of Institutions
261Shares Held
51.6MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$199 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$134 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.4MShares$59.4 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.25MShares$55.9 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.15MShares$53.4 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.14B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...